• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Simo Arredouani, PhD


  • Nowak M, Arredouani MS, Tun-Kyi A, Schmidt-Wolf I, Sanda MG, Balk SP, Exley MA.Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with alpha-galactosylceramide.PLoS ONE. 2010;5(6):e11311.
  • Arredouani MS, Tseng-Rogenski SS, Hollenbeck BK, Escara-Wilke J, Leander KR, Defeo-Jones D, Hwang C, Sanda MG.Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice.Prostate. 2010 Jun 15;70(9):1002-11.
  • Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA, Sanda MG.Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.Clin Cancer Res. 2009 Sep 15;15(18):5794-802.
  • Haram KM,Peltier HJ,Lu B,Bhasin M,Otu HH,Choy B,Regan M,Libermann TA,Latham GJ,Sanda MG,Arredouani MS.Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.Prostate. 2008 Oct 1;68(14):1517-30.
  • Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.Prostate. 2008 May 15;68(7):715-27.
  • Limmon GV, Arredouani M, McCann KL, Corn Minor RA, Kobzik L, Imani F.Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA.FASEB J. 2008 Jan;22(1):159-67.
  • Arredouani MS, Franco F, Imrich A, Fedulov A, Lu X, Perkins D, Soininen R, Tryggvason K, Shapiro SD, Kobzik L.Scavenger Receptors SR-AI/II and MARCO Limit Pulmonary Dendritic Cell Migration and Allergic Airway Inflammation.J Immunol. 2007 May 1;178(9):5912-20.
  • Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, Kobzik L.Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II.J Clin Invest. 2007 Mar;117(3):757-64.
  • Arredouani MS, Palecanda A, Koziel H, Huang YC, Imrich A, Sulahian TH, Ning YY, Yang Z, Pikkarainen T, Sankala M, Vargas SO, Takeya M, Tryggvason K, Kobzik L.MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages.J Immunol. 2005 Nov 1;175(9):6058-64.
  • Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, Tryggvason K, Kobzik L.The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.J Exp Med. 2004 Jul 19;200(2):267-72.